LISA DUDZIK: Open Payments
NPI 1700946720 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 78 payments from 27 companies in 2025. Trend: 2023 $983 · 2024 $1,793 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $291 |
| PFIZER INC. | 9 | $159 |
| Novartis Pharmaceuticals Corporation | 7 | $154 |
| Eisai Inc. | 5 | $129 |
| ARGENX US, INC. | 4 | $125 |
| HARMONY BIOSCIENCES LLC | 3 | $97 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Celgene Corporation | 5 | $94 |
| Genentech USA, Inc. | 3 | $85 |
| Biogen, Inc. | 3 | $73 |
Products named: NURTEC ODT, QULIPTA, KESIMPTA, Leqembi, VYVGART HYTRULO, WAKIX, INGREZZA, ZEPOSIA.
Industry payments across CO — which companies pay providers there.
